Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI) annual report, 2017 to 2018
This report describes the Committee's work which has mainly focused on supporting the implementation of the ambitions of the UK 5-year antimicrobial resistance strategy 2013 to 2018.
ConclusionThe ability of certain antibiotics to induce biofilm formation by a tested C. jejuni strain is of concern, with respect to the effective control of disease caused by this pathogen; however, further work is required to confirm how widespread this feature is.
ConclusionThe results indicate that the rate of resistance to quinolone has gradually increased. Since ST4526 was not isolated in 2000 and 2008, it is likely that ST4526 is rapidly increasing in Japan.
ConclusionTo our knowledge, this is the first complete genome sequence of an E. asburiae isolate co-producing IMP-8, CTX-M-14, CTX-M-3 and QnrS1. This genome may facilitate the understanding of the resistome, pathogenesis and genomic features of Enterobacter cloacae complex (ECC) and will provide valuable information for accurate identification of ECC.
As the number of antibiotics supplied through the NHS Urgent Medicine Supply Advanced Service increases, concerns are growing over its impact on antimicrobial resistance.
Antimicrobial resistance (AR) is a public health issue since it limits the choices to treat infections by Escherichia coli in humans and animals. In Brazil, the ovine meat market has grown in recent years, but studies about AR in sheep are still scarce. Thus, this study aims to investigate the presence of AR in E. coli isolated from lambs during feedlot. To this end, feces from 112 lambs with 2 months of age, after weaning, were collected on the first day of the animals in the feedlot (day 0), and on the last day before slaughtering (day 42). Isolates were selected in MacConkey agar supplemented with 4 mg/L of ceftiofur an...
England ’s outgoing chief medical officer has been appointed as the UK’s first special envoy on antimicrobial resistance.
(University of Liverpool) The University of Liverpool (UoL) and the Liverpool School of Tropical Medicine (LSTM) have been awarded £ 3.54 million for a research project that aims to develop a 'personalized health' approach to prevent and treat antimicrobial resistance (AMR).
Multi-drug resistant bacteria are seen increasingly and there are gaps in our understanding of the complexity of antimicrobial resistance, partially due to a lack of appropriate statistical tools. This hampers...
ConclusionIn a tropical climate setting, the WHO-modified EBHR formulation containing 0.5% glycerol led to better ratings of skin tolerance than the original formulation, and, therefore, may offer the best balance between skin tolerance and antimicrobial efficacy.
£5m initiative is part of a wider drive to reduce transmission of infections Related items fromOnMedica NI launches ‘One Health’ plan to tackle antimicrobial resistance Campaign aims to cut £256 million prescription fraud Doctors can help overcome ‘vaccine hesitancy’ Chief medical officer to step down in September Teething gels to come off supermarket shelves